Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: November 6, 2000
Last updated: June 6, 2012
Last verified: April 2002
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):